Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation ...

You know those men who see a woman backing into a parking spot and immediately decide that they should start directing her and giving her “help,” even though she’s done the same maneuver a thousand ...

Then the guidance shifted and people were urged to mask up even out of doors, with the CDC’s website offering instructions on how to make a mask using hair elastics and T-shirt fabric.

You know those men who see a woman backing into a parking spot and immediately decide that they should start directing her ...

Tip: The dress code for the pop-up is floral shirts to match the theme ... This Friday at 9 pm, Marcelo López will perform at Clásica y Moderna, presenting the show "Blues, Rock n Roll, and ...

Moderna fell to a new 52-week low after some disappointing news. The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has ...

A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.

Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%.

Moderna's partnership with Merck in personalized cancer therapies and promising Phase III trials support a speculative 'Buy' for long-term investors with high-risk tolerance. Despite a tough 2024 ...

Moderna’s stock price has dropped about 60% in the past 12 months. Facing this set of challenges, Moderna in September laid out a plan to cut annual R&D spending by more than 20%, or $1.1 ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...